Skip to main content
Equibles

Virtus Investment Advisers, LLC

Position in PHAT — Phathom Pharmaceuticals, Inc.

CIK 19481 HARTFORD, CT
Back to PHAT Full portfolio

Position in PHAT

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$1,216,708
+$572,484 QoQ
Shares Held
112,139
+93.4% QoQ
Ownership
0.139%
of shares outstanding
% of Portfolio
0.28%
of 13F equity value
Holder Rank
#57
of 161 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in PHAT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Virtus Investment Advisers, LLC holds $130,556,170 across 185 Biotechnology names. PHAT ranks #46 (0.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 INCY
Incyte Corp
 29,544 $3,349,107
2 ALNY
Alnylam Pharmaceuticals, Inc.
 9,953 $2,996,151
3 REGN
Regeneron Pharmaceuticals, Inc.
 4,320 $2,693,692
4 MRNA
Moderna, Inc.
 23,300 $1,631,699
5 RARE
Ultragenyx Pharmaceutical Inc.
 47,757 $1,594,606
6 PGEN
Precigen, Inc.
 261,322 $1,489,535
7 AGIO
Agios Pharmaceuticals, Inc.
 39,473 $1,464,843
8 RYTM
Rhythm Pharmaceuticals, Inc.
 13,158 $1,460,932

All Filings in PHAT

Export CSV
6 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,216,708 112,139
2026-03-31 $644,224 57,986
2025-12-31 $778,684 46,937
2025-09-30 $521,481 44,306
2025-06-30 $424,894 44,306
2025-03-31 $281,924 44,964